Ototoxicity
- 2020 CPG – Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline (The Lancet Child & Adolescent Health – Free access available with registration.)
- Endorsed by the Children’s Oncology Group (COG)
- 2019 Rapid Review – Interventions for cisplatin-induced hearing loss in children and adolescents with cancer: rapid review (The Lancet Child & Adolescent Health – not available as open access)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email:
Paula Robinson, MD, MSc
Senior Manager, Supportive Care and Guidelines
Related Articles
Bruce Power and supplier partners donate $100,000 to Pediatric Oncology Group of Ontario
Originally published on the Bruce Power website, September 25, 2024
Antibacterial ProphylaxisAntifungal ProphylaxisChemotherapy-Induced Nausea & VomitingAcute delayed Phase CINVAnticipatory CINVBreakthrough & Refractory CINVEmetogenicity ClassificationAcute & Delayed Phase CINVChronic Pain*Clostridium Difficile InfectionFatigueFertility Preservation*MucositisOtotoxicityFever and NeutropeniaPlatelet Transfusion*Venous Thromboembolism*
Care Pathways
YOU can be a champion for kids with cancer!
With your help, we will ensure that kids and youth with cancer, their families and survivors of childhood cancer have equitable access to the best care for the best possible outcomes.